NUS team creates new material for flexible soft robots
Singapore | News | 0 Comment | 27 Nov, 2019
Origami robots are state-of-the-art soft and flexible robots that are being tested for use in various applications inclu...Read more
New Breakthrough Treatment for Patients with ALK-Positive Lung Cancer
Singapore | News | 0 Comment | 26 Nov, 2019
Pfizer on 25th Nov 2019, announced that a new breakthrough therapy, LORVIQUA has been approved by Health Sciences Author...Read more
Pfizer Unveils Positive Results for VIZIMPRO® as first-line monotherapy in NSCLC patients
Singapore | News | 0 Comment | 26 Nov, 2019
Pfizer Inc. on 25th Nov 2019, announced the efficacy and tolerability results from the subgroup analysis of Asian patien...Read more
Merck presented Data on Tepotinib for NSCLC at ESMO Asia 2019
Singapore | News | 0 Comment | 25 Nov, 2019
Merck, a leading science and technology company, on 25 Nov 2019, announced the presentation of multiple abstracts on tep...Read more
5th ESMO Asia Congress highlights Asia’s increasing Cancer Burden
Singapore | News | 0 Comment | 25 Nov, 2019
The ESMO Asia Congress 2019 came to a close on 24th Nov 2019, after three days of thought-provoking lectures a...Read more
Flu vaccination lessen the preventable burden of flu in diabetics
Singapore | News | 0 Comment | 25 Nov, 2019
A team of researchers at Singapore on 22 Nov 2019 revealed the need for improved flu protection amongst those living wit...Read more
Singapore to establish Smart Digital and Multiplex Path lab
Singapore | News | 0 Comment | 26 Nov, 2019
A!maginostic (A!), an A*STAR spin-off that specialises in computational digital pathology, and ...Read more
ESMO Asia Congress 2019: Explores Advances in cancer prevention, treatment and care
Singapore | News | 0 Comment | 22 Nov, 2019
The ESMO Asia Congress returned for its fifth edition at the Suntec Singapore Convention & Exhibition Centre, on 22n...Read more
Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC
Singapore | News | 0 Comment | 22 Nov, 2019
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves over...Read more
Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer
Singapore | News | 0 Comment | 22 Nov, 2019
The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epi...Read more
Singapore makes progress in war against diabetes
Singapore | News | 0 Comment | 22 Nov, 2019
The Ministry of Health (MOH) in Singapore has released a summary report highlighting the key initiatives and progress ma...Read more
Medtech startup Eko.ai clinches Startup SG's SLINGSHOT 2019 top prize
Singapore | News | 0 Comment | 15 Nov, 2019
Eko.ai was awarded the Startup SG grand prize of S$250,000 Startup SG grant at SLINGSHOT 2019 powered by Startup SG, org...Read more
PMR launches report on "Secure Messaging in Healthcare Market"
Singapore | News | 0 Comment | 21 Nov, 2019
Secure messaging in healthcare is set to become a billion-dollar market by 2029, as indicated by a new research study. W...Read more
Chronic Stress-related Illness is the Largest Health Expenditure facing Health Systems
Singapore | News | 0 Comment | 21 Nov, 2019
The impact of stress-related conditions on Singapore’s health system conservatively equates to US$2.3 billion of s...Read more
Singapore’s Inaugural SFF x SWITCH sees over 60,000 participants from 140 countries
Singapore | News | 0 Comment | 19 Nov, 2019
The Singapore FinTech Festival (SFF) and the Singapore Week of Innovation and TeCHnology (SWITCH) concluded its combined...Read more
Duke-NUS introduces Clinical Sciences PhD programme in translational research
Singapore | News | 0 Comment | 21 Nov, 2019
Duke-NUS Medical School’s PhD programme in Clinical Sciences (PhD CS) addresses an important need in the field, by...Read more
Biofourmis announces acquisition of Biovotion AG
Singapore | News | 0 Comment | 19 Nov, 2019
Biofourmis has announced that it has reached an agreement to acquire Zürich, Switzerland-based Biovotion AG, develo...Read more
Biofourmis collaborates with Novartis for patients with heart failure
Singapore | News | 0 Comment | 19 Nov, 2019
Singapore founded Biofourmis, global leader in digital therapeutics based in Boston, announced that it has been selected...Read more